GBP/USD 1.364 EUR/GBP 0.862 GBP/JPY 197.561 EUR/USD 1.176 GBP/AUD 2.079 USD/JPY 144.821 USD/CAD 1.359 AUD/USD 0.656 CAD/JPY 106.544 EUR/CAD 1.599 GBP/CAD 1.854 AUD/CAD 0.892 AUD/JPY 95.030 AUD/NZD 1.084 EUR/AUD 1.792 GBP/USD 1.364 EUR/GBP 0.862 GBP/JPY 197.561 EUR/USD 1.176 GBP/AUD 2.079 USD/JPY 144.821 USD/CAD 1.359 AUD/USD 0.656 CAD/JPY 106.544 EUR/CAD 1.599 GBP/CAD 1.854 AUD/CAD 0.892 AUD/JPY 95.030 AUD/NZD 1.084 EUR/AUD 1.792
CURRENCY .wiki

Finance News – Pharmaceuticals

What is your interest today?

Quartz • Jun 27, 2025

The weight loss drug boom has barely begun. How big can it get?

The rising popularity of GLP-1 medications, including Ozempic, positions them to generate substantial revenue, potentially surpassing established blockbuster drugs like statins in...

Read Full Article →
City A.M. • Jun 19, 2025

UK business set to gain big from India trade deal, says minister

The recently established trade agreement between the UK and India is expected to enhance economic opportunities for companies in sectors like finance, healthcare, and education by...

Read Full Article →
Quartz • Jun 09, 2025

Pfizer and other drug companies make 'no commitments' to the White House on lower drug prices

Pfizer’s reluctance to guarantee reduced medication costs highlights ongoing challenges in achieving significant price cuts despite recent government efforts aimed at lowering expe...

Read Full Article →
Euronews Business • May 13, 2025

Bayer shares soar as company records strong cancer drug demand

Bayer’s pharmaceutical segment significantly boosted its revenue in the first quarter, contributing to a notable increase in share value despite underperformance in the agricultura...

Read Full Article →
Business Insider Markets • May 13, 2025

Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Fennec Pharmaceuticals demonstrated increased income during the initial quarter of 2025, driven by strategic sales efforts and improved assistance for patients, reflecting overall...

Read Full Article →
CNBC Business • May 05, 2025

Trump signs order to boost domestic drug manufacturing as pharma tariffs loom

The directive aims to enhance domestic production of medications, potentially reducing reliance on imports and impacting the cost structure of pharmaceuticals in the U.S. market.

Read Full Article →
The Guardian – Business • May 05, 2025

Americans would suffer most if Trump imposes pharma tariffs, sector warns

Imposing tariffs on pharmaceutical imports could disrupt supply chains and increase medication costs, potentially making essential treatments less accessible for many individuals a...

Read Full Article →